Quotient Sciences and Acesion Pharma Partner on AI-Driven Drug Development
This partnership applies AI to drug development, potentially accelerating pharmaceutical innovation and improving treatments.
This partnership applies AI to drug development, potentially accelerating pharmaceutical innovation and improving treatments.
Auto-scored: It is a minor-framing announcement with low risk and a partial beneficial step in AI for medicine.